Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XCEL-MT-OSTEO-BETA in Proximal Femur Fractures
NCT02630836Phase 2Withdrawn
- Sponsor
- Banc de Sang i Teixits
- Start
- Dec 2015
- Primary completion
- Dec 2017
- Modality
- Mesenchymal Stem Cells
01
Overview
A Phase 2 trial of XCEL-MT-OSTEO-BETA in proximal femur fracture (PFF), sponsored by Banc de Sang i Teixits. Planned start Dec 2015; status: withdrawn.
02
Drugs
XCEL-MT-OSTEO-BETA
03
Conditions
proximal femur fracture (PFF)
Beyond the preview
Go deeper on NCT02630836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02630836.